Type 3 cytokines IL-17A and IL-22 drive TGF-β–dependent liver fibrosis
The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Abstract
Type 3 immune response defined by increased IL-22 production drives fibrosis during chronic liver injury via enhanced TGF-β signaling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17A exhibited similar pro-fibrotic activity in both animal studies and in human cells124,125”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [125]
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Reciprocal T H 17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid
Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M., & Cheroutre, H. (2007) · Science · doi:10.1126/science.1145697 · Cited by 1,982 · cited 3×
“3, eaar7754 (2018) 26 October 2018 12 of 15 TGF- is essential for the differentiation of both TH17 and Tregs (42) and given the reported plasticity between these two cell subsets (19), it is possible that liver inflammation mediated by TNF-, IL-1, and IL-6 indirectly promotes differentiation of Tregs into TH17 cells a…”
BackgroundInfluentialPathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809 · cited 3×
“Transforming growth factor– (TGF-) signaling is the key fibrogenic signal that activates hepatic stellate cells (HSCs), the main producer of extracellular matrix in the liver, and is modulated by proinflammatory mediators such as cytokines that act on HSCs and liver immune cells (1).”
BackgroundInfluentialThe aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J.-C., & Stockinger, B. (2008) · Nature · doi:10.1038/nature06881 · Cited by 1,634
Type 2 immunity in tissue repair and fibrosis
Gieseck, R. L., Wilson, M. S., & Wynn, T. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.90 · Cited by 1,055 · cited 2×
“Type 2 inflammation, characterized by production of IL-4, IL-5, IL-10, IL-13, IL-25, and IL-33, is associated with reduced hepatic inflammation but correlates with progression of liver fibrosis (4).”
BackgroundTh17 and regulatory T cell balance in autoimmune and inflammatory diseases
Noack, M., & Miossec, P. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.12.004 · Cited by 932 · cited 4×
“The ratio between Tregs and other inflammatory cells is one of the key determinants of the progression of inflammatory diseases (18).”
BackgroundInfluentialMast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
Lin, A. M., Rubin, C. J., Khandpur, R., Wang, J. Y., Riblett, M., Yalavarthi, S., Villanueva, E. C., Shah, P., Kaplan, M. J., & Bruce, A. T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100123 · Cited by 906 · cited 1×
“IL-17–producing mast cells are associated with disease progression in rheumatoid arthritis and psoriasis (40, 41), suggesting that they may have a similar function in the liver.”
BackgroundThe 3 major types of innate and adaptive cell-mediated effector immunity
Annunziato, F., Romagnani, C., & Romagnani, S. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.11.001 · Cited by 818 · cited 2×
“The inflammatory response can be divided into three types (2).”
BackgroundMeng, F., Wang, K., Aoyama, T., Grivennikov, S. I., Paik, Y., Scholten, D., Cong, M., Iwaisako, K., Liu, X., Zhang, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.049 · Cited by 711 · cited 1×
“Although TH17 cells were not the principal source of IL-17 in situ, they may enhance recruitment of innate effectors through induction of proinflammatory chemokines by endothelial cells (7).”
Backgroundthe Immunological Genome Consortium, Robinette, M. L., Fuchs, A., Cortez, V. S., Lee, J. S., Wang, Y., Durum, S. K., Gilfillan, S., & Colonna, M. (2015) · Nature Immunology · doi:10.1038/ni.3094 · Cited by 641
Cited by
Fibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
Dewidar, B., Meyer, C., Dooley, S., & Meindl-Beinker, A. N. (2019) · Cells · doi:10.3390/cells8111419 · Cited by 837
“Also, inhibiting IL-22 or IL-17 production by aryl hydrocarbon receptor or RAR-related orphan receptor γ antagonists improved fibrosis [136].”
BackgroundHepatic inflammatory responses in liver fibrosis
Hammerich, L., & Tacke, F. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00807-x · Cited by 803
“T H 17 cells drive liver fibrosis via the production of IL-17 and IL-22, which stimulate transforming growth factor-β (TGFβ) production in the liver, enhance TGFβ signalling in HSCs, and induce the production of collagen by HSCs and pro-inflammatory cytokines by both HSCs and Kupffer cells 120–122 .”
Harrell, C., Fellabaum, C., Jovicic, N., Djonov, V., Arsenijevic, N., & Volarevic, V. (2019) · Cells · doi:10.3390/cells8050467 · Cited by 501
“Hyun and coworkers highlighted the importance of microRNA (miR)-125b-bearing MSC-Exos which suppressed pro-fibrotic function of HSCs by impeding activation of Hedgehog/Smoothened signaling pathway in these cells [82].”
BackgroundInfluentialMechanisms of liver fibrosis and its role in liver cancer
Dhar, D., Baglieri, J., Kisseleva, T., & Brenner, D. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370219898141 · Cited by 429
“Neutrophils and mast cells can also be a major producer of IL-17 in fibrotic liver.(41) IL-17 is a profibrogenic cytokine which stimulates HSCs to increase levels of collagen type I, a-SMA, and TGF-b by activating NF-jB and STAT3.”
Background
Metadata
- Authors
- Fabre, T., Molina, M. F., Soucy, G., Goulet, J.-P., Willems, B., Villeneuve, J.-P., Bilodeau, M., & Shoukry, N. H.
- Affiliations
- Centre Hospitalier de l’Université de Montréal (CA)
- Caprion (Canada) (CA)
- Corresponding author
- Shoukry, Naglaa H.
- ORCID
- Venue
- Science Immunology
- Published
- 2018-10-26
- Volume
- 3
- Issue
- 28
- ISSN
- 2470-9468 (ISSN-L)
- OpenAlex
- W2898290288
- Cited by
- 155
- References
- 52
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 19 · 2023: 23 · 2022: 23 · 2021: 25 · 2020: 15 · 2019: 7 · 2018: 1
- FWCI
- 7.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (HEO-115696)
- Fonds de Recherche du Québec - Santé
- Canadian Liver Foundation (N/A)
- Fonds de recherche du Québec – Santé (FRQS) AIDS and Infectious Disease Network
- Canadian Network on Hepatitis C
- Novartis/Canadian Liver Foundation Hepatology Research Chair (N/A)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- liver fibrosis, IL-17A, IL-22, TGF-beta signaling, hepatic stellate cells, p38 MAPK, neutrophils, mast cells, IL-22RA1, aryl hydrocarbon receptor, chronic liver injury, thioacetamide, carbon tetrachloride
- MeSH terms
- Interleukin-22, Animals, Azo Compounds, Disease Models, Animal, Dose-Response Relationship, Drug, Female, Interleukins, Liver Cirrhosis, Male, Mice, Inbred C57BL, Pyrazoles, Transforming Growth Factor beta, Mice, Knockout, Interleukin-17, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.